Sustained generation and survival of antigen-specific CD62Lhigh CD8+ T-cells through in vitro conditioning with interleukin-12: Implications for anti-tumor adoptive immunotherapy.

被引：0
|
作者：
Diaz-Montero, C. Marcela [1 ]
Kadima, Andre [1 ]
El-Naggar, Sabry A. [1 ]
Nath, Narender [1 ]
Cole, David J. [1 ]
Salem, Mohamed L. [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC 29425 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5578
引用
收藏
页数：2
相关论文
共 49 条
  • [31] Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells
    Brandon J. Burbach
    Stephen D. O’Flanagan
    Qi Shao
    Katharine M. Young
    Joseph R. Slaughter
    Meagan R. Rollins
    Tami Jo L. Street
    Victoria E. Granger
    Lalit. K. Beura
    Samira M. Azarin
    Satish Ramadhyani
    Bruce R. Forsyth
    John C. Bischof
    Yoji Shimizu
    Nature Communications, 12
  • [32] A Nanobody Against Cytotoxic T-Lymphocyte Associated Antigen-4 Increases the Anti-Tumor Effects of Specific CD8+ T Cells
    Tang, Zhuoran
    Mo, Fengzhen
    Liu, Aiqun
    Duan, Siliang
    Yang, Xiaomei
    Liang, Liu
    Hou, Xiaoqiong
    Yin, Shihua
    Jiang, Xiaobing
    Vasylieva, Natalia
    Dong, Jiexian
    Barnych, Bogdan
    Hammock, Bruce D.
    Lu, Xiaoling
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2019, 15 (11) : 2229 - 2239
  • [33] Generation of highly activated, antigen-specific tumor-infiltrating CD8+T cells induced by a novel T cell-targeted immunotherapy
    Vila-Leahey, Ava
    MacKay, Alecia
    Portales-Cervantes, Liliana
    Weir, Genevieve M.
    Merkx-Jacques, Alexandra
    Stanford, Marianne M.
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [34] Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15:: Potential for adoptive T cell immunotherapy
    Chen, HW
    Liao, CH
    Ying, CW
    Chang, CJ
    Lin, CM
    CLINICAL IMMUNOLOGY, 2006, 119 (01) : 21 - 31
  • [35] B-lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8+ T-cells
    Ritchie, DS
    Yang, J
    Hermans, IF
    Ronchese, F
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (06) : 543 - 551
  • [36] Synergy of brief activation of CD8 T-cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memory
    Diaz-Montero, C. Marcela
    Naga, Osama
    Zidan, Abdel-Aziz A.
    Salem, Mohamed L.
    Pallin, Maria
    Parmigiani, Anita
    Walker, Gail
    Wieder, Eric
    Komanduri, Krishna
    Cole, David J.
    Montero, Alberto J.
    Lichtenheld, Mathias G.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2011, 1 (07): : 882 - 896
  • [37] Dendritic cells engineered to secrete interleukin-12 P70 when delivered into tumors results in the crosspriming of an expanded anti-tumor CD8+ T cell repertoire and therapeutic benefit
    Komita, Hideo
    Storkus, Walter J.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 896 - 896
  • [38] Priming of naive CD8+T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine model
    Diaz-Montero, C. Marcela
    El Naggar, Sabry
    Al Khami, Amir
    El Naggar, Randa
    Montero, Alberto J.
    Cole, David J.
    Salem, Mohamed L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (04) : 563 - 572
  • [39] Anti-tumor effect and generation of tumor-specific CD8+ T-cells after combined Flt3L and GM-CSF mobilization and dendritic cell therapy
    Björck, P
    Falo, LD
    Storkus, WJ
    FASEB JOURNAL, 2001, 15 (05): : A1200 - A1200
  • [40] Rescue of Notch-1 Signaling in Antigen-Specific CD8+ T Cells Overcomes Tumor-Induced T-cell Suppression and Enhances Immunotherapy in Cancer
    Sierra, Rosa A.
    Thevenot, Paul
    Raber, Patrick L.
    Cui, Yan
    Parsons, Chris
    Ochoa, Augusto C.
    Trillo-Tinoco, Jimena
    Del Valle, Luis
    Rodriguez, Paulo C.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (08) : 800 - 811
12345